New Trends of Cervical Cancer Incidence in Kazakhstan.


Journal

Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625

Informations de publication

Date de publication:
01 04 2021
Historique:
received: 29 01 2021
entrez: 28 4 2021
pubmed: 29 4 2021
medline: 24 11 2021
Statut: epublish

Résumé

The epidemiological features of the cervical cancer (CC) incidence and its spatial and temporal assessment in Kazakhstan were studied. The retrospective study was done for the period 2009-2018. Descriptive and analytical methods of oncoepidemiology were used. During the study period, 16,441 new cases of CC were registered. The average annual crude and age-standardized incidence rate were 18.6±0.5 and 17.7±0.4 cases per 100,000 population of female, respectively, and their trends tended to increase (Тup=+2.3%; R2=0.708 and Тup=+1.9%; R2=0.615, respectively). The analysis of ASIR showed unimodal growth with a peak at 50-54 years - 45.3±1.1 cases per 100,000 population of female. Trends of ASIR decreased up to 30 years (Tdown=-1.8%; R2=0.111) and 35-59 years (Tdown=-0.9%; R2=0.103), in other age groups the trends increased, and were most pronounced in 40-44 (Тup=+4.1%; R2=0.878) and 65-69 years (Тup=+4.4%; R2=0.537). Trends in ASR of СС tended to grow in almost all regions, with higher levels in Mangystau (Тup=+4.1%; R2=0.482) and Aktobe (Тup=+6.3%; R2=0.846) regions. The cartograms of ASR per 100,000 population of female were allocated according to the following criteria: low - up to 16.3, average - from 16.3 to 19.2, high - above 19.2. The results of the spatial analysis showed the regions with a higher levels of CC incidence rate per 100,000 population of female: East Kazakhstan (19.8), Aktobe (20.0), Almaty (20.1), Kostanay region (20.9), Atyrau (21.7) regions and Almaty city (22.0). The study of trends of the cervical cancer incidence has the theoretical and practical value:  monitoring and evaluation of screening programmes, which are implemented in the country, and conduction of secondary prevention of cervical pathology. Health authorities should consider the obtained results in the in the organization of anti-cancer activities.

Identifiants

pubmed: 33906325
doi: 10.31557/APJCP.2021.22.4.1295
pmc: PMC8325133
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1295-1304

Références

Ecancermedicalscience. 2019 Jul 25;13:952
pubmed: 31552125
Chin J Cancer Res. 2020 Dec 31;32(6):720-728
pubmed: 33446995
Annu Rev Microbiol. 1994;48:427-47
pubmed: 7826013
Eur J Cancer. 2016 Aug;63:1-10
pubmed: 27254837
Saf Health Work. 2012 Sep;3(3):166-80
pubmed: 23019529
Oncol Lett. 2015 Aug;10(2):600-606
pubmed: 26622540
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Biomed Res Int. 2020 Jun 16;2020:4945608
pubmed: 32685493
Asian Pac J Cancer Prev. 2019 Apr 29;20(4):1089-1096
pubmed: 31030478
J Glob Oncol. 2016 May 25;2(5):311-340
pubmed: 28717717
Oncol Lett. 2015 Mar;9(3):1015-1026
pubmed: 25663851
Bull World Health Organ. 2001;79(10):954-62
pubmed: 11693978
Asian Pac J Cancer Prev. 2018 May 26;19(5):1175-1180
pubmed: 29801397
Obstet Gynecol. 2010 Sep;116(3):578-582
pubmed: 20733438
Front Oncol. 2016 Jun 28;6:160
pubmed: 27446806
Obstet Gynecol Clin North Am. 2007 Dec;34(4):739-60, ix
pubmed: 18061867
J Gynecol Oncol. 2015 Jul;26(3):232-9
pubmed: 26197860
CA Cancer J Clin. 2020 Sep;70(5):321-346
pubmed: 32729638
Asian Pac J Cancer Prev. 2012;13(5):2345-8
pubmed: 22901220

Auteurs

Nurbek Igissinov (N)

Astana Medical University, Nur-Sultan, Kazakhstan.
Central Asian Cancer Institute, Nur-Sultan, Kazakhstan.
Eurasian Institute for Cancer Research, Bishkek, Kyrgyzstan.

Gulnur Igissinova (G)

Central Asian Cancer Institute, Nur-Sultan, Kazakhstan.
Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.

Zhansaya Telmanova (Z)

Astana Medical University, Nur-Sultan, Kazakhstan.
Central Asian Cancer Institute, Nur-Sultan, Kazakhstan.

Zarina Bilyalova (Z)

Central Asian Cancer Institute, Nur-Sultan, Kazakhstan.

Dariyana Kulmirzayeva (D)

Central Asian Cancer Institute, Nur-Sultan, Kazakhstan.
National Center for Neurosurgery, Nur-Sultan, Kazakhstan.

Zhanar Kozhakhmetova (Z)

Astana Medical University, Nur-Sultan, Kazakhstan.
Central Asian Cancer Institute, Nur-Sultan, Kazakhstan.

Saltanat Urazova (S)

Astana Medical University, Nur-Sultan, Kazakhstan.

Dulat Turebayev (D)

Astana Medical University, Nur-Sultan, Kazakhstan.

Gaukhar Nurtazinova (G)

Astana Medical University, Nur-Sultan, Kazakhstan.

Ardak Omarbekov (A)

Astana Medical University, Nur-Sultan, Kazakhstan.

Aigul Almabayeva (A)

Astana Medical University, Nur-Sultan, Kazakhstan.

Zhanar Bukeyeva (Z)

Astana Medical University, Nur-Sultan, Kazakhstan.

Dinara Tarzhanova (D)

Astana Medical University, Nur-Sultan, Kazakhstan.

Altyn Moldabayeva (A)

Astana Medical University, Nur-Sultan, Kazakhstan.

Marina Zhanaliyeva (M)

Astana Medical University, Nur-Sultan, Kazakhstan.

Ainagul Kazbekova (A)

Astana Medical University, Nur-Sultan, Kazakhstan.

Vladimir Openko (V)

Astana Medical University, Nur-Sultan, Kazakhstan.

Saken Kozhakhmetov (S)

Astana Medical University, Nur-Sultan, Kazakhstan.
Central Asian Cancer Institute, Nur-Sultan, Kazakhstan.

Yerlan Kuandykov (Y)

Khoja Akhmet Yassawi International Kazakh-Turkish University, Turkistan, Kazakhstan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH